Improving patient-specific dosimetry for intravascular brachytherapy.

Abstract:

PURPOSE:Accurate patient-specific dosimetry in intravascular brachytherapy (IVBT) is generally difficult due to the extremely high-dose gradient, complexity of treatment device, and patient-specific geometry (e.g., calcification, stent, curvature, movement of target). The purpose of this study is to analyze quantitatively and systematically the dose effects of calcification, stent, guidewire, and source curvature on clinical dosimetry in an IVBT procedure, and propose a method that can be used to assess these effects in routine clinical practice. METHODS AND MATERIALS:Monte Carlo techniques were used to calculate 3-D dose distribution in both homogeneous and inhomogeneous media for three most commonly used IVBT sources: (90)Sr beta (Novoste), (192)Ir gamma (Cordis/Best), and (32)P beta (Guidant). Dosimetric perturbations in the presence of metallic stents, calcified plaques, metallic guide wires, and source curvature were studied for situations commonly encountered in the clinic. The importance of each of these perturbations and their practical influence on patient-specific dosimetry were analyzed. Factors (plaque, stent, guidewire, and curvature) that may be used to correct/reduce these perturbations were introduced to prevent dosimetric cold spots during IVBT. Practical methods of using these correction factors are proposed. RESULTS:Dose perturbations are significant due to the presence of source curvature, metallic stents, calcified plaques, and metallic guide wires, especially for beta sources. These perturbations can be as high as 30% under normal clinical conditions, although they can be much higher in extreme situations. Empirical relationships of plaque factor with the thickness of calcified plaque, stent factor with stent metallic surface area, guidewire with guidewire thickness, and curvature factor with the bending angle are derived. These relationships are found to be useful in improving clinical dose accuracy in IVBT treatment planning or dose evaluation after treatment. CONCLUSIONS:Significant dose perturbations due to the presence of source curvature, metallic stents, calcified plaques, and guide wires have been found in IVBT for in-stent restenosis. Because it has been reported that, with the current prescriptions for IVBT, higher doses consistently improve treatment outcomes, the empirical method derived from this work can be used to assess cold spots dosimetrically, thus improving patient-specific dosimetry for IVBT.

journal_name

Brachytherapy

journal_title

Brachytherapy

authors

Li XA,O'Neill M,Suntharalingam M

doi

10.1016/j.brachy.2005.07.004

keywords:

subject

Has Abstract

pub_date

2005-01-01 00:00:00

pages

291-7

issue

4

eissn

1538-4721

issn

1873-1449

pii

S1538-4721(05)00109-1

journal_volume

4

pub_type

杂志文章
  • The effect of obesity on rectal dosimetry after permanent prostate brachytherapy.

    abstract:OBJECTIVES:Men with higher body mass index (BMI) tend to have more fatty tissue in prostate-rectum interface, which may reduce the rectal wall dose by the inverse square law. We hypothesized that men with higher BMI will have a lower dose to the rectal wall and less rectal toxicity after permanent prostate implant. ME...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2008.12.001

    authors: Patil N,Crook J,Saibishkumar EP,Aneja M,Borg J,Pond G,Ma C

    更新日期:2009-04-01 00:00:00

  • Process improvement for the safe delivery of multidisciplinary-executed treatments-A case in Y-90 microspheres therapy.

    abstract:PURPOSE:To develop a safe and robust workflow for yttrium-90 (Y-90) radioembolization procedures in a multidisciplinary team environment. METHODS AND MATERIALS:A generalized Define-Measure-Analyze-Improve-Control (DMAIC)-based approach to process improvement was applied to a Y-90 radioembolization workflow. In the fir...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.08.001

    authors: Cai B,Altman MB,Garcia-Ramirez J,LaBrash J,Goddu SM,Mutic S,Parikh PJ,Olsen JR,Saad N,Zoberi JE

    更新日期:2017-01-01 00:00:00

  • Evaluating the influence of prostate-specific antigen kinetics on metastasis in men with PSA recurrence after partial gland therapy.

    abstract:PURPOSE:Although current Delphi Consensus guidelines do not recommend a specific definition of biochemical recurrence after partial gland therapy, these guidelines acknowledge that serial prostate-specific antigen (PSA) tests remain the best marker for monitoring disease after treatment. The purpose of this study was t...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2018.12.001

    authors: King MT,Nguyen PL,Boldbaatar N,Yang DD,Muralidhar V,Tempany CM,Cormack RA,Hurwitz MD,Suh WW,Pomerantz MM,D'Amico AV,Orio PF 3rd

    更新日期:2019-01-01 00:00:00

  • Clinical outcome of high-dose-rate interstitial brachytherapy in vulvar cancer: A single institutional experience.

    abstract:PURPOSE:With an aim to evaluate and report high dose date interstitial brachytherapy (HDR-ISBT) in vulvar cancers, we undertook this retrospective analysis. METHODS AND MATERIALS:Histologically proven vulvar cancers treated with HDR-ISBT between 2001 and 2016 were analyzed. Radiotherapy details, clinical outcome in te...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.10.003

    authors: Mahantshetty U,Naga P,Engineer R,Sastri S,Ghadi Y,Upreti U,Somesan V,Kadam S,Kohle S,Deshpande D,Shrivastava SK

    更新日期:2017-01-01 00:00:00

  • High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary results.

    abstract:PURPOSE:Although high-dose-rate brachytherapy (HDRBT) offers significant advantages over low dose rate brachytherapy, there are scant data on improved local control (LC) and treatment-related complications in patients with recurrent head and neck (H&N) cancers. We report our preliminary results in patients with recurre...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2006.12.001

    authors: Narayana A,Cohen GN,Zaider M,Chan K,Lee N,Wong RJ,Boyle J,Shaha A,Kraus D,Shah J,Zelefsky MJ

    更新日期:2007-04-01 00:00:00

  • Evaluation of impact of an external breast shield (FlexiShield) in electronic brachytherapy for breast IORT: A phantom study.

    abstract:PURPOSE:To investigate Axxent (iCAD, Inc., San Jose, CA) electronic brachytherapy balloon deformation and its dosimetric impact because of an external flexible shield (FlexiShield [FS]; iCAD, Inc.). METHODS AND MATERIALS:Prostheses breast tissue phantom overlaid three spherical balloon applicators to simulate three cl...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.01.009

    authors: Kim Y,Huynh JW,Gonzalez VJ

    更新日期:2017-01-01 00:00:00

  • Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI.

    abstract:PURPOSE:To quantify needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer and propose a threshold for needle migration. METHODS AND MATERIALS:Twenty-four high-risk prostate cancer patients treated with an HDR boost of 2 × 8.5 Gy were included. Patients received an MRI for planning ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.08.005

    authors: Buus S,Lizondo M,Hokland S,Rylander S,Pedersen EM,Tanderup K,Bentzen L

    更新日期:2018-01-01 00:00:00

  • Prospective evaluation of patient satisfaction after the use of brachytherapy specific educational materials for cervical cancer.

    abstract:BACKGROUND:Cervical cancer patients are faced with an enormous amount of medical information in a complex oncology field with sophisticated treatments including brachytherapy. We investigated the use of enhanced vs. standard brachytherapy-specific educational materials on patient-reported satisfaction during the inform...

    journal_title:Brachytherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.brachy.2015.09.007

    authors: Rash D,Hess C,Lentz S,Tait L,Michaud A,Mayadev J

    更新日期:2016-01-01 00:00:00

  • Racial differences in the PSA bounce in predicting prostate cancer outcomes after brachytherapy: Evidence from the Department of Veterans Affairs.

    abstract:PURPOSE:African American men have historically had poorer prostate cancer biochemical and survival outcomes than Caucasians. However, emerging data suggest nononcologic factors drive much of this disparity. Prior evidence has suggested an association between a transient prostate specific antigen (PSA) bounce and improv...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.08.008

    authors: Slade AN,Dahman B,Chang MG

    更新日期:2020-01-01 00:00:00

  • Single-energy metal artifact reduction in postimplant computed tomography for I-125 prostate brachytherapy: Impact on seed identification.

    abstract:PURPOSE:To evaluate the effectiveness of the single-energy metal artifact reduction (SEMAR) technique for improving the accuracy of I-125 seed identification in postimplant computed tomography (CT) after prostate brachytherapy. METHODS AND MATERIALS:Postimplant CT images of 40 patients treated with I-125 prostate brac...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.07.006

    authors: Shiraishi Y,Yamada Y,Tanaka T,Eriguchi T,Nishimura S,Yoshida K,Hanada T,Ohashi T,Shigematsu N,Jinzaki M

    更新日期:2016-01-01 00:00:00

  • A comparative dosimetric analysis of virtual stereotactic body radiotherapy to high-dose-rate monotherapy for intermediate-risk prostate cancer.

    abstract:PURPOSE:Stereotactic body radiotherapy (SBRT) is being used with increasing frequency as definitive treatment of early stage prostate cancer. Much of the justification for its adoption was derived from earlier clinical results using high-dose-rate (HDR) brachytherapy. We determine whether HDR's dosimetry can be achieve...

    journal_title:Brachytherapy

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.brachy.2013.03.003

    authors: Spratt DE,Scala LM,Folkert M,Voros L,Cohen GN,Happersett L,Katsoulakis E,Zelefsky MJ,Kollmeier MA,Yamada Y

    更新日期:2013-09-01 00:00:00

  • Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.

    abstract:PURPOSE:Marriage has been associated with enhanced survival among cancer patients, but conflicting correlations have been suggested in cervical cancer. We assessed the impact of marital status on receipt of brachytherapy and survival in women with locally advanced cervical cancer. METHODS AND MATERIALS:Three thousand,...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.04.273

    authors: Huynh-Le MP,Klapheke A,Cress R,Mell LK,Yashar CM,Einck JP,Mundt AJ,Mayadev JS

    更新日期:2019-01-01 00:00:00

  • An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial.

    abstract:PURPOSE:To compare dose-volume histogram variables for the internal and external urinary sphincters (IUS/EUS) with urinary quality of life after prostate brachytherapy. METHODS AND MATERIALS:Subjects were 42 consecutive men from a prospective study of brachytherapy as monotherapy with (125)I for intermediate-risk loca...

    journal_title:Brachytherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.brachy.2012.10.006

    authors: Register SP,Kudchadker RJ,Levy LB,Swanson DA,Pugh TJ,Bruno TL,Frank SJ

    更新日期:2013-05-01 00:00:00

  • Multicatheter breast implant during breast conservative surgery: Novel approach to deliver accelerated partial breast irradiation.

    abstract:PURPOSE:To assess the safety, feasibility, and efficacy of free-hand intraoperative multicatheter breast implant (FHIOMBI) and perioperative high-dose-rate brachytherapy (PHDRBT) in early breast cancer. METHODS AND MATERIALS:Patients with early breast cancer candidates for breast conservative surgery (BCS) were prospe...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.03.001

    authors: Cambeiro M,Martinez-Regueira F,Rodriguez-Spiteri N,Olartecoechea B,Insausti LP,Elizalde A,Gastearena MI,Gallego JS,Santisteban M,Aramendía JM,Aristu JJ,Moreno LA,Moreno-Jiménez M,Valtueña G,Martínez-Monge R

    更新日期:2016-07-01 00:00:00

  • High-dose-rate interstitial brachytherapy in oral cancer-Its impact on quality of life.

    abstract:PURPOSE:The aim of the study was to assess the impact of high-dose-rate (HDR) interstitial brachytherapy on quality of life (QOL) in oral cancer. METHODS AND MATERIALS:Thirty-two patients of oral cancer treated at our institute from January 2010 to December 2014 with radical radiotherapy (external beam radiotherapy + ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.02.002

    authors: Bajwa HK,Singareddy R,Alluri KR

    更新日期:2016-05-01 00:00:00

  • The effect of isotope selection on the prostate-specific antigen response in patients treated with permanent prostate brachytherapy.

    abstract:PURPOSE:To assess the difference in prostate-specific antigen (PSA) response kinetics in patients undergoing either (125)I or (103)Pd permanent prostate brachytherapy (PPB). METHODS AND MATERIALS:Between 1997 and 1999, 333 patients underwent PPB as monotherapy. Forty-eight patients received a (125)I implant, and 285 r...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/S1538-4721(03)00004-7

    authors: Potters L,Huang D,Fearn P,Kattan MW

    更新日期:2003-01-01 00:00:00

  • Clinical outcomes of high-dose-rate brachytherapy and external beam radiotherapy in the management of clinically localized prostate cancer.

    abstract:PURPOSE:To report prostate-specific antigen (PSA) relapse-free survival and treatment-related toxicity outcomes after combining high-dose-rate (HDR) brachytherapy with external beam radiotherapy (EBRT) for patients with clinically localized prostate cancer. METHODS AND MATERIALS:Between 1998 and 2009, 229 patients wer...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2012.05.003

    authors: Kotecha R,Yamada Y,Pei X,Kollmeier MA,Cox B,Cohen GN,Zaider M,Zelefsky MJ

    更新日期:2013-01-01 00:00:00

  • Impact of experience and technical changes on acute urinary and rectal morbidity in low-dose prostate brachytherapy using loose seeds real-time implantation.

    abstract:PURPOSE:To assess the impact of experience and technical changes on morbidity during the first year after permanent prostate brachytherapy. METHODS AND MATERIALS:From July 2003 to May 2010, 150 patients with prostate cancer underwent low-dose iodine-125 prostate brachytherapy as a monotherapy by the same medical team ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2013.04.002

    authors: Le Fur E,Malhaire JP,Nowak E,Rousseau B,Erauso A,Pene-Baverez D,Papin G,Delage F,Perrouin-Verbe MA,Fournier G,Pradier O,Valeri A

    更新日期:2013-11-01 00:00:00

  • MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity.

    abstract:PURPOSE:To establish dose-volume effect correlations for late small bowel (SB) toxicities in patients treated for locally advanced cervical cancer with concomitant chemoradiation followed by pulsed-dose rate MRI-guided adaptive brachytherapy. METHODS AND MATERIALS:Patients treated with curative intent and followed pro...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.04.004

    authors: Petit C,Dumas I,Chargari C,Martinetti F,Maroun P,Doyeux K,Tailleur A,Haie-Meder C,Mazeron R

    更新日期:2016-07-01 00:00:00

  • Clinical factors and dosimetry associated with the development of prostate brachytherapy-related urethral strictures: A matched case-control study.

    abstract:PURPOSE:Urethral strictures are a rare complication of prostate brachytherapy (BXT), with prior studies showing radiation dose to the bulbomembranous urethra as being associated with stricture formation. This retrospective case-control study explored clinical and dosimetric parameters associated with the development of...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.04.242

    authors: Singhal S,Jamaluddin MF,Lee E,Sloboda RS,Parliament M,Usmani N

    更新日期:2017-01-01 00:00:00

  • GERICO-03 phase II trial of accelerated and partial breast irradiation in elderly women: feasibility, reproducibility, and impact on functional status.

    abstract:PURPOSE:To analyze the feasibility, reproducibility, and impact on functional status of postoperative accelerated and partial breast irradiation (APBI) using interstitial high-dose rate-brachytherapy in women older than 70 years. METHODS AND MATERIALS:From July 2004 to April 2008, 46 patients were screened for enrollm...

    journal_title:Brachytherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.brachy.2012.06.004

    authors: Hannoun-Levi JM,Gourgou-Bourgade S,Belkacemi Y,Chara-Bruneau C,Hennequin C,Quetin P,Orsini C,Brain E,Marsiglia H

    更新日期:2013-07-01 00:00:00

  • Dose homogeneity analysis of adjuvant radiation treatment in surgically resected brain metastases: Comparison of IORT, SRS, and IMRT indices.

    abstract:PURPOSE:Although surgery remains a treatment option for symptomatic brain metastases, the need for adjuvant radiation after surgery is widely accepted as standard. Despite a multitude of randomized trials aimed at identifying the ideal radiation treatment plan for surgically resected metastases, the development of new ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2020.11.004

    authors: Dahshan BA,Weir JS,Bice RP,Renz P,Cifarelli DT,Poplawski L,Hack J,Vargo JA,Cifarelli CP

    更新日期:2021-01-13 00:00:00

  • A pilot study of intraluminal brachytherapy using 125I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice.

    abstract:PURPOSE:To investigate the safety and feasibility of intraluminal brachytherapy using 125I seed strand for locally advanced pancreatic ductal adenocarcinoma with obstructive jaundice. METHODS AND MATERIALS:From January 2010 to February 2015, 18 consecutive patients diagnosed with locally advanced, nonmetastatic, inope...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.05.004

    authors: Yang M,Yan Z,Luo J,Liu Q,Zhang W,Ma J,Zhang Z,Yu T,Zhao Q,Liu L

    更新日期:2016-01-01 00:00:00

  • Comparison of outcome endpoints in intermediate- and high-risk prostate cancer after combined-modality radiotherapy.

    abstract:PURPOSE:To compare a standard radio-oncological and a surgical biochemical failure definition after combined-modality radiation therapy (CRT) in men with intermediate- and high-risk prostate cancer. METHODS:425 men were treated with external beam radiotherapy (59.4 Gy, 33 fractions) and 125J seed-brachytherapy (S-BT, ...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.09.001

    authors: Boehle A,Katic K,König IR,Robrahn-Nitschke I,Brandenburg B

    更新日期:2020-01-01 00:00:00

  • Moving toward uniform and evidence-based practice of radiotherapy for management of cervical cancer in Ontario, Canada.

    abstract:PURPOSE:To recognize the practice of radiotherapy for management of cervical cancer in Ontario, Canada, and to use the results of the survey to harmonize and standardize practice across the province. METHODS AND MATERIALS:An electronic survey (SurveyMonkey) was sent to all 14 provincial cancer centers by Cancer Care O...

    journal_title:Brachytherapy

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.brachy.2018.03.003

    authors: Shahid N,Craig T,Westerland M,Ashworth A,Ang M,D'Souza D,Sankreacha R,Fyles A,Milosevic M,Kong I,Cancer Care Ontario Radiation Treatment Gynecologic Oncology Community of Practice.

    更新日期:2018-01-01 00:00:00

  • Monte Carlo calculation of the dose perturbations in a dual-source HDR/PDR afterloader treatment unit.

    abstract:PURPOSE:Currently, there are high dose rate afterloaders available that can drive two different radioactive sources simultaneously. The source-source and source-cable attenuations are not taken into account by current planning systems. The purpose of this work is to characterize these effects and their overall impact o...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2016.03.007

    authors: Collins-Fekete CA,Plamondon M,Verhaegen F,Beaulieu L

    更新日期:2016-07-01 00:00:00

  • Clinical outcomes using image-guided interstitial brachytherapy for definitive cervical cancer patients with high-risk clinical target volumes greater than 30 cc.

    abstract:PURPOSE:Given the limited data using an interstitial approach with 3D-based planning for definitive cervical cancer utilizing the GEC-ESTRO defined high-risk clinical target volume (HR-CTV), we reviewed our institutional experience of cervical cancer patients with HR-CTVs ≥ 30 cc to determine whether our clinical and t...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2017.10.004

    authors: Wang C,Raince J,Swamy U,Park SJ,Zaide L,Mesko S,Demanes DJ,Kamrava M

    更新日期:2018-01-01 00:00:00

  • Long-term efficacy and urological toxicity of low-dose-rate brachytherapy (LDR-BT) as monotherapy in localized prostate cancer.

    abstract:PURPOSE:The purpose of this study was to evaluate the incidence of late severe (≥Grade 3) urinary toxicity and the long-term efficacy after low-dose-rate brachytherapy (LDR-BT) in patients with localized prostate cancer (PCa). METHODS AND MATERIALS:During the years 1999-2008, 241 patients with PCa who underwent LDR-BT...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2019.05.005

    authors: Vuolukka K,Auvinen P,Palmgren JE,Voutilainen T,Aaltomaa S,Kataja V

    更新日期:2019-01-01 00:00:00

  • Interstitial brachytherapy in the management of persistent head and neck disease after definitive external beam radiation therapy.

    abstract:PURPOSE:Persistent disease after definitive external beam radiation therapy for head and neck (H&N) malignancies negatively impacts survival. In this series, the effectiveness of low-dose-rate brachytherapy in the management of persistent H&N disease is explored. METHODS:All patients who received brachytherapy for per...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2008.12.007

    authors: Grimard L,Esche B,Lamothe A,Spaans JN

    更新日期:2009-07-01 00:00:00

  • Changes in brachytherapy-based APBI patient selection immediately before and after publication of the ASTRO consensus statement.

    abstract:PURPOSE:In July 2009, American Society of Radiation Oncology (ASTRO) released a consensus statement (CS) to guide patient selection for accelerated partial breast irradiation (APBI). The goal of this study was to examine how practice patterns changed following the guideline's release. METHODS:The Surveillance, Epidemi...

    journal_title:Brachytherapy

    pub_type: 杂志文章

    doi:10.1016/j.brachy.2015.03.003

    authors: Husain ZA,Lloyd S,Shah C,Wilson LD,Koshy M,Mahmood U

    更新日期:2015-07-01 00:00:00